ea0059p199 | Reproduction | SFEBES2018
Patel Aaran
, Abbara Ali
, Chia Germaine
, Eng Pei
, Phylactou Maria
, Clarke Sophie
, Comninos Alexander
, Trew Geoffrey
, Kelsey Tom
, Salim Rehan
, Dhillo Waljit
Background: During IVF treatment, a pharmacological dose of recombinant FSH (rFSH) is used to induce multi-follicular growth (controlled ovarian stimulation; COS). An insufficient dose of rFSH negatively impacts the number of oocytes retrieved, whereas an excessive dose risks the potentially life-threatening complication ovarian hyperstimulation syndrome. Hence, appropriate rFSH dosing is regarded as a key treatment decision affecting both the success and safety of...